Piramal’s latest FDA reprimand comes after the company disclosed the receipt of a separate Form 483 at its API facility in Michigan last February. (hudiemm/iStock/Getty Images Plus) Roughly a year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results